Aflac Incorporated (NYSE:AFL – Get Free Report) declared a quarterly dividend on Wednesday, July 31st, RTT News reports. Stockholders of record on Wednesday, August 21st will be paid a dividend of 0.50 per share by the financial services provider on Monday, September 2nd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.91%. The ex-dividend date of this dividend is Wednesday, August 21st.
Aflac has increased its dividend by an average of 14.5% annually over the last three years and has raised its dividend every year for the last 43 years. Aflac has a payout ratio of 28.4% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Aflac to earn $6.85 per share next year, which means the company should continue to be able to cover its $2.00 annual dividend with an expected future payout ratio of 29.2%.
Aflac Price Performance
Shares of NYSE AFL opened at $104.76 on Monday. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The company has a market capitalization of $59.53 billion, a PE ratio of 11.56, a P/E/G ratio of 2.76 and a beta of 0.95. The firm has a fifty day simple moving average of $93.33 and a 200 day simple moving average of $86.89. Aflac has a twelve month low of $72.78 and a twelve month high of $104.90.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on AFL. Truist Financial raised their price objective on shares of Aflac from $82.00 to $100.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. UBS Group raised their price target on shares of Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a report on Wednesday, August 14th. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a report on Friday, May 3rd. Citigroup increased their price objective on shares of Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 23rd. Finally, Wells Fargo & Company boosted their target price on Aflac from $81.00 to $90.00 and gave the company an “equal weight” rating in a research report on Monday, August 12th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $90.62.
Get Our Latest Research Report on Aflac
Insider Buying and Selling
In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of Aflac stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total transaction of $197,880.00. Following the transaction, the director now owns 18,158 shares of the company’s stock, valued at approximately $1,796,552.52. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, Director Thomas J. Kenny sold 2,000 shares of the stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total transaction of $197,880.00. Following the completion of the transaction, the director now owns 18,158 shares in the company, valued at $1,796,552.52. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Charles D. Lake II sold 22,378 shares of the business’s stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $87.47, for a total transaction of $1,957,403.66. Following the completion of the transaction, the director now owns 61,522 shares in the company, valued at $5,381,329.34. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles
- Five stocks we like better than Aflac
- What Is WallStreetBets and What Stocks Are They Targeting?
- The Worst May Be Over for Cisco After Beating Estimates in Q4
- 3 Ways To Invest In Coffee, Other Than Drinking It
- This Small Cap Wealth Management Stock Could Provide Big Returns
- Best Stocks Under $10.00
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.